Animal & Veterinary

Animal Drugs at FDA Phase 2 Implementation

June 8, 2017

In our continued effort to improve transparency and public access to information about approved animal drugs, the U.S. Food and Drug Administration’s Center for Veterinary Medicine is launching Phase 2 of the redesigned Animal Drugs @ FDA website.

As before, the new Animal Drugs @ FDA website provides a searchable database for veterinarians, pet owners, animal producers and others to get information about approved animal drugs by application number, sponsor name, proprietary name, ingredient, application status, dosage form, route of administration, indication and species.

The completion of Phase II on June 8, 2017 provides a “one-stop shop” for additional information related to approved animal drugs, including the migration of the following documents from FDA.gov:

  • Freedom of Information Summaries
  • Environmental Assessments
    • Findings of No Significant Impact
  • Green Book reports

These existing documents will be transitioned from FDA.gov to Animal Drugs @ FDA over the next several months, with users being directed to the new location.

In addition, all Green Book reports will now be available immediately, instead of being published annually. These “real-time” reports will be provided in Portable Document Format (PDF) and Microsoft Excel formats.

For more information about the redesigned Animal Drugs @ FDA, contact CVMGreenBookandAnimalDrug@fda.hhs.gov.

 

Contact FDA

240-402-7002
240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

7519 Standish Place, HFV-1

Rockville, MD 20855

Page Last Updated: 06/08/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English